Today: 5 March 2026
Browse Category

Stock Market 6 November 2025

Fastly (FSLY) Soars After Record Q3: Security Revenue +30%, Guidance Raised; Shares Jump ~26% on Nov. 6, 2025

Fastly (FSLY) Soars After Record Q3: Security Revenue +30%, Guidance Raised; Shares Jump ~26% on Nov. 6, 2025

Fastly shares surged 26% intraday after reporting record Q3 revenue of $158.2 million, up 15% year over year, and raising guidance for Q4 and FY2025. Security revenue jumped 30% to $34 million, now 21% of total sales. Non-GAAP gross margin reached 62.8%, and free cash flow turned positive at $18.1 million. RBC and Piper Sandler raised price targets, citing improved fundamentals.
Salesforce (CRM) Tumbles ~6%: Wall Street Targets Diverge, Options Flow Turns Mixed, and Q3 FY26 Results Land on Dec. 3

Salesforce (CRM) Tumbles ~6%: Wall Street Targets Diverge, Options Flow Turns Mixed, and Q3 FY26 Results Land on Dec. 3

Salesforce shares dropped about 6% Thursday, among the steepest declines in the Dow, as software stocks broadly retreated. Analysts’ 12-month price targets range from $221 to $430, with consensus near $325 and most ratings at “Buy.” Options trading this week showed mixed sentiment and high volatility. Salesforce reports Q3 FY26 results after the bell on Dec. 3.
Stocks Slip as Tech Wobble Returns; Layoffs Spike and Tariff Showdown Clouds Outlook — Stock Market Today (Nov. 6, 2025)

Stocks Slip as Tech Wobble Returns; Layoffs Spike and Tariff Showdown Clouds Outlook — Stock Market Today (Nov. 6, 2025)

U.S. stocks opened lower Thursday as investors weighed weak private jobs data and mixed earnings. Challenger reported over 150,000 announced layoffs in October, the highest for the month in more than 20 years. The dollar fell for a second day as traders raised odds of a December Fed rate cut. Qualcomm and DoorDash dropped on company risks; Datadog and Moderna gained on strong results.
Centrus Energy (LEU) launches $1B at-the-market equity program after Q3 results; stock slides on Nov. 6, 2025

Centrus Energy (LEU) launches $1B at-the-market equity program after Q3 results; stock slides on Nov. 6, 2025

Centrus Energy launched a $1 billion at-the-market equity program, replacing its previous 2024 ATM, with Barclays, Citi, UBS, and Evercore ISI leading the syndicate. Q3 2025 revenue rose 30% year-over-year to $74.9 million, but the company posted a $4.3 million gross loss. Shares fell about 16% intraday to $271.78 following the announcements.
PlayStation Portal Gets Cloud Streaming Today (Nov. 6, 2025): Stream Select PS5 Digital Games Without Your Console On — New UI, 3D Audio, and In‑Game Purchases

PlayStation Portal Gets Cloud Streaming Today (Nov. 6, 2025): Stream Select PS5 Digital Games Without Your Console On — New UI, 3D Audio, and In‑Game Purchases

Sony launched full cloud streaming for PS5 games on PlayStation Portal for PlayStation Plus Premium members, starting Nov. 5 at 6 p.m. PT. Users can now stream select PS5 digital titles without connecting to a PS5. The update adds a redesigned UI, 3D audio, network status tools, and more. Patch 6.0.0 also brings minor improvements such as PSN profile viewing and expanded Quick Menu access.
6 November 2025
Cummins (CMI) Q3 2025: Revenue $8.32B, Adjusted EPS $5.59; Dividend Lifted to $2.00 as Data‑Center Power Drives Beat and Accelera Faces Strategic Review

Cummins (CMI) Q3 2025: Revenue $8.32B, Adjusted EPS $5.59; Dividend Lifted to $2.00 as Data‑Center Power Drives Beat and Accelera Faces Strategic Review

Cummins reported Q3 revenue of $8.32 billion and adjusted EPS of $5.59, both above estimates, driven by strong data-center power demand. The company raised its quarterly dividend to $2.00 and launched a strategic review of its Accelera electrolyzer business after $240 million in non-cash charges. Shares rose 7.6% by midafternoon. No 2025 outlook was issued.
McConnell’s Hemp Crackdown Collides With Retail THC Boom: Big Brands, 39 AGs, and Congress Face a ‘Hemp War’ (Nov. 6, 2025)

McConnell’s Hemp Crackdown Collides With Retail THC Boom: Big Brands, 39 AGs, and Congress Face a ‘Hemp War’ (Nov. 6, 2025)

The Consumer Brands Association, representing Coca‑Cola, Nestlé, and others, urged Congress to ban intoxicating hemp products in FY26 spending talks. Thirty-nine state attorneys general renewed calls to tighten hemp’s legal definition. The Senate previously removed a House-backed hemp ban from a key bill, but negotiations continue. Meanwhile, Circle K and Target are expanding hemp-THC beverage sales as states impose new restrictions.
Krispy Kreme (DNUT) Q3 2025: Adjusted EPS Turns Positive, Free Cash Flow Returns as Turnaround Gains Traction — Nov. 6, 2025

Krispy Kreme (DNUT) Q3 2025: Adjusted EPS Turns Positive, Free Cash Flow Returns as Turnaround Gains Traction — Nov. 6, 2025

Krispy Kreme reported Q3 2025 revenue of $375.3 million, down 1.2% year over year, but posted a surprise adjusted EPS of $0.01, beating expectations for a loss. Shares jumped as the company reiterated guidance for stronger cash flow into year-end. Net loss was $20.1 million, or –$0.11 per share GAAP. Global points of access fell 6.1% after closing underperforming locations.
Strive Asset Management (ASST) prices upsized 12% preferred stock IPO to raise ~$160M; fresh Semler (SMLR) merger filing lands — Nov. 6, 2025

Strive Asset Management (ASST) prices upsized 12% preferred stock IPO to raise ~$160M; fresh Semler (SMLR) merger filing lands — Nov. 6, 2025

Strive, Inc. priced an upsized offering of 2 million shares of its SATA preferred stock at $80 each, targeting $160 million in gross proceeds. The stock carries a 12% initial annual dividend and may fund Bitcoin purchases, among other uses. Semler Scientific filed an 8-K confirming Strive’s recent capital moves and Bitcoin holdings as their pending merger advances. Settlement is set for November 10, 2025.
Vistra (VST) Q3 2025: $652M Profit, 2026 EBITDA Outlook Raised to $6.8–$7.6B; Board Adds $1B Buyback

Vistra (VST) Q3 2025: $652M Profit, 2026 EBITDA Outlook Raised to $6.8–$7.6B; Board Adds $1B Buyback

Vistra reported Q3 GAAP net income of $652 million and revenue of $4.97 billion, down 21% year over year. The board approved an extra $1 billion in share repurchases through 2027. The company completed 2.6 GW in gas plant acquisitions and signed a 20-year, 1,200-MW nuclear PPA. 2025 Adjusted EBITDA guidance narrowed to $5.7–$5.9 billion; 2026 guidance set at $6.8–$7.6 billion.
BIYA Soars Over 100% on November 6, 2025: Baiya International’s Volatile Rally, Massive Volume, and What to Watch Ahead of 25‑for‑1 Share Consolidation Vote

BIYA Soars Over 100% on November 6, 2025: Baiya International’s Volatile Rally, Massive Volume, and What to Watch Ahead of 25‑for‑1 Share Consolidation Vote

Shares of Baiya International Group (NASDAQ: BIYA) surged over 100% in U.S. trading Thursday, with intraday volume topping 200 million shares. No new company press release or SEC filing appeared to explain the spike. The move followed a 149% after-hours jump Wednesday and comes ahead of a Nov. 28 shareholder vote on a 25-for-1 reverse split.
6 November 2025
Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics reported Q3 2025 revenue of $67.5 million, up 13% sequentially but below analyst expectations, and a net loss of $91.3 million, or $0.25 per share. Gross margin rose to 43%. Management reaffirmed full-year revenue guidance of $250–$300 million. Over 80 U.S. treatment centers are now active, and cash reserves totaled $307 million at quarter’s end.
Novavax (NVAX) Raises 2025 Revenue Outlook After Q3 Beat; Sanofi Milestones Drive Guidance — November 6, 2025

Novavax (NVAX) Raises 2025 Revenue Outlook After Q3 Beat; Sanofi Milestones Drive Guidance — November 6, 2025

Novavax raised its FY2025 adjusted revenue outlook to $1.04–$1.06 billion after reporting Q3 revenue of $70 million, above estimates. The company posted a GAAP net loss of $202 million for the quarter, impacted by $126 million in non-cash charges tied to Maryland site consolidation and debt. Two $25 million milestone payments from Sanofi will be recognized in Q4. Cash stood at $778 million as of September 30.
DoorDash (DASH) plunges as 2026 spending plan eclipses Q3 beat — What to know today (Nov 6, 2025)

DoorDash (DASH) plunges as 2026 spending plan eclipses Q3 beat — What to know today (Nov 6, 2025)

DoorDash shares fell about 9% premarket after the company said it will boost 2026 spending by several hundred million dollars to accelerate a new global tech platform, overshadowing strong Q3 results. Revenue rose 27% to $3.45 billion and total orders climbed 21%, but EPS of $0.55 missed estimates. The Deliveroo acquisition closed Oct. 2. DoorDash’s $5 billion buyback remains unused.
D‑Wave Quantum (QBTS) Q3 2025: Revenue Doubles to $3.7M, Record $836M Cash, Bookings Accelerate — What It Means for the Stock Today

D‑Wave Quantum (QBTS) Q3 2025: Revenue Doubles to $3.7M, Record $836M Cash, Bookings Accelerate — What It Means for the Stock Today

D‑Wave Quantum posted Q3 revenue of $3.7 million, doubling year over year, with bookings jumping to $2.4 million. The company ended the quarter with a record $836.2 million in cash, boosted by warrant exercises, while GAAP net loss widened to $140 million due to $121.9 million in non-cash charges. Shares traded near $31 intraday. Over $12 million in additional bookings closed after quarter-end.
Arm Holdings (ARM) Beats Q2, Lifts Q3 Outlook on AI Momentum — What to Know Today (Nov. 6, 2025)

Arm Holdings (ARM) Beats Q2, Lifts Q3 Outlook on AI Momentum — What to Know Today (Nov. 6, 2025)

Arm reported fiscal Q2 revenue of $1.14 billion, up 34% year-over-year and above estimates, with non-GAAP EPS of $0.39. The company raised Q3 revenue guidance to about $1.225 billion, citing strong AI demand. Royalties climbed 21% to $620 million, licensing jumped 56% to $515 million. Major brokers raised price targets after results.
e.l.f. Beauty (ELF) plunges as tariff hit and soft FY‑2026 outlook overshadow Rhode boost: what to know today (Nov. 6, 2025)

e.l.f. Beauty (ELF) plunges as tariff hit and soft FY‑2026 outlook overshadow Rhode boost: what to know today (Nov. 6, 2025)

e.l.f. Beauty shares plunged over 20% after the company forecast FY‑2026 revenue of $1.55–$1.57 billion and adjusted EPS of $2.80–$2.85, both missing analyst estimates. Tariff costs exceeding $50 million and 75% China sourcing pressured margins, which fell 165 basis points. Q2 net sales rose 14% to $343.9 million; adjusted EPS was $0.68. Piper Sandler and UBS downgraded the stock following the guidance.
MMTec (MTC) soars 627% and then whipsaws pre‑market as Nasdaq delisting clock ticks — What to know today (Nov. 6, 2025)

MMTec (MTC) soars 627% and then whipsaws pre‑market as Nasdaq delisting clock ticks — What to know today (Nov. 6, 2025)

MMTec (NASDAQ: MTC) surged 627% on Nov. 5 before dropping 24% pre-market Nov. 6 amid heavy volatility. The moves follow a Nasdaq delisting notice over minimum bid price rules, with MMTec requesting a hearing to avoid suspension. As of 14:06 UTC, shares traded near $2.21. The company completed a 1-for-8 reverse split in December 2024.
6 November 2025
Go toTop